meglio di Nivida
Eli Lilly's Q2 revenue jumps 36% to $11.3B
Business
1h ago(Source: baha news)
EPA-EFE/RONALD WITTEK
Business
Eli Lilly and Company announced on Thursday that its revenue in the second quarter of fiscal 2024 amounted to $11.3 billion, jumping 36% year over year.
Net income and earnings per share in the reported trimester skyrocketed around 68% on an annual level, reaching $2.97 billion and $3.28 respectively. The full-year 2024 revenue guidance was raised to between $45.4 billion and $46.6 billion, from the previously expected $42.4 billion to $43.6 billion.
"Mounjaro, Zepbound and Verzenio led our strong financial performance in the second quarter as we advanced our manufacturing expansion agenda, and it is equally exciting to see the growth around the world of our medicines for cancer, neurological disorders and autoimmune diseases," CEO David Ricks said.
The company's stock added 8.84% at 6:54 am ET, going for $840.36 apiece.